Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

United Laboratories Intl

United Laboratories Intl
PUBLIC STATUS
10K-15K EMPLOYEES
03933 STOCK SYMBOL
$0.64 SHARE PRICE (As of Friday Closing)
Description

United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, capsule casings, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Intermediate products. Most of the company's sales are generated in China, followed by Europe and India.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
HKG
Primary Office
  • New Territories
  • Hong Kong
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore United Laboratories Intl’s full profile, request a free trial.

United Laboratories Intl Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.47 - $0.77 $1.05B $0.61 $0.08 3.1M 1.64B

United Laboratories Intl Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 1,267,715 1,356,852 1,921,194 1,766,762
Revenue 1,144,354 1,135,339 1,010,165 912,490
EBITDA 280,337 266,922 162,640 119,130
Net Income 130,100 103,235 12,098 (40,890)
Total Assets 2,217,150 2,122,735 2,161,513 2,155,312
Total Debt 649,063 618,184 743,947 846,640
Public Fundamental Data provided by Morningstar, Inc. disclaimer